(-0.08%) 5 464.73 points
(-0.07%) 39 084 points
(0.16%) 17 746 points
(-0.68%) $80.28
(-4.32%) $2.64
(-0.85%) $2 311.10
(0.01%) $28.87
(2.32%) $1 009.30
(0.30%) $0.936
(0.73%) $10.68
(0.48%) $0.792
(-0.27%) $87.25
-3.64% $ 7.81
Live Chart Being Loaded With Signals
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs...
Stats | |
---|---|
Volumen de hoy | 77 064 |
Volumen promedio | 84 624 |
Capitalización de mercado | 344.72M |
EPS | $-0.380 ( Q2 | 2024-04-30 ) |
Last Dividend | $0.130 ( 2015-02-02 ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.135 (1.74%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-30 | Bryce Richard Paul | Buy | 153 000 | Stock Option (Right to Buy) |
2023-11-30 | Daws D. Ryan | Buy | 232 000 | Stock Option (Right to Buy) |
2023-11-27 | Daws D. Ryan | Buy | 0 | |
2023-10-31 | Forbion Capital Fund Iii Cooperatief U.a. | Sell | 0 | Class A common shares |
2023-11-30 | Forbion Capital Fund Iii Cooperatief U.a. | Sell | 475 076 | Warrant (Right to Buy) |
INSIDER POWER |
---|
-38.61 |
Last 15 transactions |
Buy: 475 436 | Sell: 921 648 |
Volumen Correlación
enGene Holdings Inc. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
enGene Holdings Inc. Correlación - Moneda/Commodity
enGene Holdings Inc. Finanzas
Annual | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $0 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $0 |
Financial Reports:
No articles found.
enGene Holdings Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.180 | 2012-04-02 |
Last Dividend | $0.130 | 2015-02-02 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | $2.52 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
Unable to generate commentary due to missing data.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
02 Feb 2015 | $0.130 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
01 Dec 2014 | $0.140 | 01 Dec 2014 | 30 Nov -0001 | 05 Dec 2014 |
03 Nov 2014 | $0.150 | 03 Nov 2014 | 30 Nov -0001 | 07 Nov 2014 |
01 Oct 2014 | $0.150 | 01 Oct 2014 | 30 Nov -0001 | 07 Oct 2014 |
01 May 2014 | $0.130 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
02 Dec 2013 | $0.120 | 29 Nov 2013 | 30 Nov -0001 | 06 Dec 2013 |
01 Nov 2013 | $0.120 | 01 Nov 2013 | 30 Nov -0001 | 07 Nov 2013 |
01 Oct 2013 | $0.120 | 01 Oct 2013 | 30 Nov -0001 | 07 Oct 2013 |
01 Aug 2013 | $0.120 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
01 May 2013 | $0.120 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
26 Dec 2012 | $0.110 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
03 Dec 2012 | $0.110 | 03 Dec 2012 | 30 Nov -0001 | 07 Dec 2012 |
01 Nov 2012 | $0.120 | 01 Nov 2012 | 30 Nov -0001 | 07 Nov 2012 |
01 Oct 2012 | $0.120 | 01 Oct 2012 | 30 Nov -0001 | 05 Oct 2012 |
04 Sep 2012 | $0.120 | 04 Sep 2012 | 30 Nov -0001 | 10 Sep 2012 |
01 Aug 2012 | $0.120 | 01 Aug 2012 | 30 Nov -0001 | 07 Aug 2012 |
02 Jul 2012 | $0.110 | 02 Jul 2012 | 30 Nov -0001 | 09 Jul 2012 |
01 Jun 2012 | $0.110 | 01 Jun 2012 | 30 Nov -0001 | 07 Jun 2012 |
01 May 2012 | $0.120 | 01 May 2012 | 30 Nov -0001 | 07 May 2012 |
02 Apr 2012 | $0.180 | 02 Apr 2012 | 30 Nov -0001 | 09 Apr 2012 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Diamond | 2024-09-16 | Monthly | 14 | 15.03% | 9.60 |
DMLP | Dividend Diamond | 2024-04-26 | Quarterly | 22 | 10.71% | 9.35 |
OXSQ | Dividend Diamond | 2024-09-16 | Monthly | 21 | 12.73% | 9.02 |
ARLP | Dividend Royal | 2024-05-07 | Quarterly | 26 | 9.67% | 8.87 |
PNNT | Dividend Royal | 2024-06-14 | Monthly | 18 | 9.49% | 8.82 |
MFIC | Dividend Royal | 2024-06-11 | Quarterly | 21 | 10.89% | 8.79 |
SPOK | Dividend Royal | 2024-05-23 | Quarterly | 20 | 8.73% | 8.72 |
PSEC | Dividend Royal | 2024-06-25 | Monthly | 21 | 9.03% | 8.65 |
SBLK | Dividend Royal | 2024-06-06 | Quarterly | 17 | 13.10% | 8.63 |
GBDC | Dividend Royal | 2024-11-29 | Bi-Monthly | 15 | 8.53% | 8.62 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0 | 1.500 | 0 | 0 | [0 - 0.5] |
returnOnAssetsTTM | -0.413 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -1.591 | 1.500 | -10.00 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 42.80 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 42.23 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 42.04 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0902 | -1.500 | 8.50 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -11.50 | 1.000 | -5.37 | -5.37 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.903 | 2.00 | -0.301 | -0.602 | [0 - 30] |
freeCashFlowPerShareTTM | -0.928 | 2.00 | -0.464 | -0.928 | [0 - 20] |
debtEquityRatioTTM | 0.102 | -1.500 | 9.59 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0 | 1.000 | -3.33 | -3.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0 | 1.000 | -2.00 | -2.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -1.443 | 1.000 | -9.13 | -9.13 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 0.0973 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -2.83 | 1.000 | -0.387 | 0 | [1 - 100] |
returnOnEquityTTM | -1.591 | 2.50 | -10.00 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.928 | 2.00 | -0.309 | -0.928 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.903 | 2.00 | -0.301 | -0.602 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0283 | 1.500 | -3.52 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0 | 1.000 | -2.50 | 0 | [0.1 - 0.5] |
Total Score | -1.939 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
enGene Holdings Inc.
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico